EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gut microbiota dysbiosis–induced chronic inflammation as a driver of atherosclerosis: cellular crosstalk and host–microbe interactions

Da Song, Huize Gao, Tianqi Wang, Qian Wei, Aidong Liu, Jixiang Ren

Frontiers in Cellular and Infection Microbiology · 15.05.2026 · 16

DOI: 10.3389/fcimb.2026.1789194 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 15.05.2026. Verfasst von Da Song und 5 weiteren Autor:innen. Beteiligte Einrichtung: Changchun University of Chinese Medicine, Changchun, Jilin, China. Hauptthemen laut MEDLINE: Dysbiosis, Atherosclerosis, Gastrointestinal Microbiome, Inflammation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 169 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gut microbiota dysbiosis is increasingly recognized as an upstream contributor to chronic low-grade inflammation and atherosclerosis (AS). Disruption of microbial homeostasis may impair intestinal barrier integrity, increase exposure to pro-inflammatory microbial products and metabolites, and reduce protective metabolites such as short-chain fatty acids (SCFAs), thereby activating innate immune signaling and sustaining vascular inflammation. Current evidence indicates that gut dysbiosis promotes atherosclerosis mainly through three interconnected processes: metabolite imbalance, barrier dysfunction with microbial translocation, and systemic immune reprogramming. Clinical studies have linked gut-derived biomarkers, particularly trimethylamine N-oxide (TMAO) and lipopolysaccharide (LPS)-related signals, to atherosclerotic burden and adverse cardiovascular outcomes, while experimental studies using fecal microbiota transplantation, probiotics, antibiotics, and gene-deficient models support a contributory role of the gut–immune–vascular axis. Emerging interventions, including dietary modulation, pharmacological repurposing, and microbiome-targeted therapies, may attenuate gut-derived chronic inflammation and offer new strategies for AS prevention and treatment. However, heterogeneity across studies and the limited causal evidence in humans warrant cautious interpretation. Overall, gut dysbiosis-driven chronic inflammation represents a biologically meaningful and potentially modifiable pathway in atherosclerosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DysbiosisAtherosclerosisGastrointestinal MicrobiomeInflammationHost Microbial InteractionsHumansAnimalsFecal Microbiota TransplantationMethylaminesIntestinal Barrier FunctionFatty Acids, Volatile

Stichwörter der Autor:innen

atherosclerosischronic inflammationfecal microbiota transplantationgut microbiota dysbiosisshort-chain fatty acidstrimethylamine N-oxide

Substanzen

MethylaminestrimethyloxamineFatty Acids, Volatile

Autor:innen und Institutionen

  • Changchun University of Chinese Medicine, Changchun, Jilin, China.
  • Department of Gastric and Colorectal Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun, China.
  • The Third Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, Jilin, China.
  • The Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, Jilin, China.

Zitieren

APA

Song, D., Gao, H., Wang, T., Wei, Q., Liu, A., & Ren, J. (2026). Gut microbiota dysbiosis–induced chronic inflammation as a driver of atherosclerosis: cellular crosstalk and host–microbe interactions. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1789194

Vancouver

Song D, Gao H, Wang T, Wei Q, Liu A, Ren J. Gut microbiota dysbiosis–induced chronic inflammation as a driver of atherosclerosis: cellular crosstalk and host–microbe interactions. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1789194

BibTeX
@article{Song2026,
  author = {Song, Da and Gao, Huize and Wang, Tianqi and Wei, Qian and Liu, Aidong and Ren, Jixiang},
  title = {Gut microbiota dysbiosis–induced chronic inflammation as a driver of atherosclerosis: cellular crosstalk and host–microbe interactions},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fcimb.2026.1789194}
}
Kostenlos starten →